Guest Editors
Prof. Dr. Kuo-Hu Chen
Email: alexgfctw@yahoo.com.tw; alexgfctw@mail.tcu.edu.tw
Affiliation: 1. School of Medicine, Tzu-Chi University, Hualien, 97004, Taiwan
2. Department of Obstetrics and Gynecology, Taipei Tzu-Chi GeneralHospital, Hualien, 970, Taiwan
3. Taiwan Association for Minimally Invasive Gynecology, Taoyuan, 3330, Taiwan
4. Taiwan Association of Gynecology, Taipei, 100, Taiwan
5. Taiwan Endometriosis Society, Taipei, 110, Taiwan
Homepage:
Research Interests: gynecologic oncology, minimally invasive gynecologic surgery,endometriosis, polycystic ovary syndrome (PCOS), high-risk pregnancy; obstetric/ gynecologic epidermiology
Summary
Dear Colleagues,
I am organizing a Special Issue titled "New advance in gynecologic oncology" in thejournal Oncology Research, a peer-reviewed journal that publishes articles and communications in the interdisciplinary area of Oncology.
Women's health is a major concern all over the world. During their lives, women may encounter the invasion of gynecologic cancers including ovarian cancer, cervical cancer, uterine corpus, and endometrial cancer, many of which maybe unexpected and have a huge percussion on the patients and their families. The gynecologic cancer per se and relevant complications significantly influence the life span and quality of the affected women. The related healthcare has been an important issue and remains to be explored.
This Special Issue solicits any original contributions and reviews that explore the nature of diseases, associated therapies, and health impacts on women and even their families in different countries and communities. Studies discussing health issues mentioned aboveare suitable for consideration in the special issue. Advances or any cutting-edge research in affected women'shealthcare are especially welcome to be published. The listed keywords suggest just a few of the many possibilities.
Keywords
gynecologic cancer, tumor marker, ovarian cancer, endometrial cancer, uterine cancer, cervical cancer, chemotherapy, target therapy, immune therapy